April 25, 2018 / 11:20 AM / 7 months ago

BRIEF-Synlogic Receives Fast-Track Designation For Synb1618, A Synthetic Biotic Medicine For Treatment Of Phenylketonuria

April 25 (Reuters) - Synlogic Inc:

* SYNLOGIC RECEIVES FAST-TRACK DESIGNATION FOR SYNB1618, A SYNTHETIC BIOTIC™ MEDICINE FOR THE TREATMENT OF PHENYLKETONURIA

* SYNLOGIC INC - PHASE 1/2A CLINICAL STUDY OF SYNB1618 EXPECTED TO REPORT INTERIM DATA IN 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below